The Testicular Cancer Resource Center |
History
Testicular cancer used to be a brutal killer. If you were diagnosed with nonseminoma, you had to have a complete Retroperitoneal Lymph Node Dissection because it was the only thing that could possibly cure the cancer. If you had Stage III testicular cancer, little could be done. Back in 1970, about 90% of testicular cancer patients died of their disease.
The 70's brought us the success of Cisplatin which, when used in combination with other chemotherapy drugs and the appropriate use of surgery, brought the cure rate to an astounding 80%! This chemotherapy is not pleasant, but it's profound success has allowed the doctors to decrease the toxicity of all of the various testicular cancer treatments because they know that they have a chemotherapy safety net. The surgeries used have become less drastic with fewer side effects; surveillance has become an option; and the chemotherapy, which was once given continuously for two YEARS, is now limited to 9-12 weeks. Yes, it is not perfect. People still die of their disease. But it is a far better world for testicular cancer patients than it was 30 years ago.
We asked one of our world class testicular cancer experts, Dr. Craig Nichols, to provide a little more history and an explanation as to why this chemotherapy works so well.
He tells us that this is, "Literally a Nobel Prize question. I can tell you why these agents were selected, but the actual mechanisms of action and why this combination works so well in this disease and hardly at all in others is unknown. In the pre cisplatin era, there were a variety of single agents that had some small level of activity in testis cancer. It was also noted that two agents in particular, vinblastine and bleomycin, seemed to have not just additive effects but synergism."
"In 1973 here at Indiana, Dr. Einhorn recognized that cisplatin had activity in testis cancer and also that it was a perfect drug for combining with the best agents of the time. Cisplatin had dominantly nausea/vomiting and kidney toxicity whereas vinblastine had bone marrow toxicity and bleomycin had lung toxicity. He realized that these agents could be combined in full doses and give the three best agents in this disease simultaneously. Therein lies the tale, because with the addition of cisplatin the cure rate went from 10% to 80% (with the addition of adjunctive surgery as necessary.) [Editor's note: Vinblastine was replaced by Etoposide in the 1980's. It has fewer side effects and is slightly more effective.]"
"We believe these agents kill the tumor cells by crosslinking DNA, disrupting the ability to divide and also accelerating programmed cell death. The trillion dollar question is what is unique about germ cells relative to other solid tumors that allows this exquisite sensitivity. This is not well understood (at this time)."
Agents and Protocols
The chemotherapy protocols used for testicular cancer vary from country to country and even from hospital to hospital. That makes life a little more complicated, but in general, there are two accepted chemotherapy protocols for good risk testicular cancer: Either 3 cycles of BEP (Bleomycin, Etoposide, and Cisplatin) or 4 cycles of EP (Etoposide and Cisplatin). The standard protocols used in the US call for the cisplatin and etoposide to be given, inpatient or outpatient, over a period of 5 days. Some other countries and some experimenters in the US have tried to give the chemo over a period of 1-3 days, but in my opinion, they are really trying to save money more than they are trying to benefit the patient. Also, in Europe they tend to use less Etoposide per cycle.
For intermediate and poor risk germ cell tumors, the standard protocol is 4 cycles of BEP. Some institutions use a protocol called VIP (Etoposide, Ifosfamide, and Cisplatin) and/or use high dose chemo with a stem cell transplant (Carboplatin and Etoposide) to treat poor risk patients. Typically, the stem cell transplant is not used outside of a clinical trial.
Please note that Carboplatin, while related to Cisplatin, is
not as effective as Cisplatin. It should never be used to treat
nonseminomatous germ cell tumors except during a stem cell transplant.
AFP, alpha-fetoprotein; hCG, human chorionic gonadotropin; LDH, lactate dehydrogenase; ULN, upper limit of normal.
Adapted from International Germ Cell Cancer Collaborative Group Some countries in Europe (particularly the UK and Germany) plus a few
sites in the US are now recommending 2 cycles of adjuvant chemo for
patients with high risk stage I nonseminoma. Their thought is that if
they can't see the spread of cancer on CT scan, but the pathology report
indicates that it is likely to have spread, then they can save the
patient from surgery or excessive chemo by giving them just two cycles
of BEP chemo right away. Unfortunately, neither I nor most of the
experts I have talked with agree with this thinking.
To Chemo or Not to Chemo...
So, who needs chemo? Well, in my opinion, men with documented Stage
II or III testicular cancer are candidates for chemotherapy. Some with
stage II seminoma can be treated with chemotherapy or radiation. Some
with Stage II nonseminoma can be treated with surgery or chemotherapy.
Men with Stage III seminoma or nonseminoma and men with Stage I
nonseminoma and abnormal tumor markers that have not dropped to normal
(Stage IS) must be treated with chemotherapy.
Men with Stage IS and Stage II
cancer should probably receive 3 cycles of BEP or four cycles of EP.
Depending on the severity of the disease, most men with Stage III cancer
can be also cured with one of these standard protocols. Men with
advanced Stage III cancer or a mediastinal extragonadal germ cell tumor
should probably get 4 cycles of BEP or investigate a clinical trial into
the use of high dose chemotherapy. If there is ever any question as to
how much chemo you really need, please have your doctor consult with one
of our experts!
The two protocols (EP and BEP) are essentially identical in terms of
cure rate. They are different in terms of length and possible side
effects. The BEP protocol uses less Cisplatin and Etoposide, but uses
Bleomycin. Bleomycin can cause lung fibrosis in older patients (over
fifty) and can be a problem in patients with extensive lung metastases
or existing lung problems. Etoposide can cause leukemia many years down
the road (at the levels given during standard chemo, the risk is less
than 1 percent.) and Cisplatin can cause neuropathy and hearing loss, so
there is some impetus to reduce the number of cycles of these drugs.
Which should YOU choose? Well, you usually won't be asked. These
protocols typically vary from hospital to hospital. Memorial Sloan
Kettering strongly prefers EP while Indiana University prefers BEP. If
you have any concerns, please discuss them with your doctor before
starting chemotherapy...
Risk
Seminomatous tumors
Nonseminomatous tumors
Good
Any primary site
and
No nonpulmonary visceral metastasis
and
Normal AFP,
any hCG,
any LDH level
Testicular or retroperitoneal primary tumor
and
No nonpulmonary visceral metastasis
and
Good markers (all of the following):
AFP <1,000 ng/mL
hCG <5,000 mIU/mL
LDH <1.5 x ULN
Intermediate
Any primary site
and
Nonpulmonary visceral metastasis
and
Normal AFP,
any hCG,
any LDH level
Testicular or retroperitoneal primary tumor
and
No nonpulmonary visceral metastasis
and
Intermediate markers (any of the following):
AFP 1,000-10,000 ng/mL
hCG 5,000-50,000 mIU/mL
LDH 1.5-10 x ULN
Poor
None
Mediastinal primary tumor
or
Nonpulmonary visceral metastasis
(brain, liver, bone, etc.)
or
Poor markers (any of the following):
AFP >10,000 ng/mL
hCG >50,000 mIU/mL
LDH >10 x ULN
In recent years, particularly in Europe, one or two cycles of adjuvant Carboplatin are being recommended to treat Stage I seminoma. Studies do exist implying that this treatment is just as effective as radiation in reducing short term recurrences, but there is less evidence that it is as effective in reducing long term recurrences.
Nevertheless, most men with Stage I Seminoma are cured by the orchiectomy alone, and while this Carboplatin treatment is very quick and relatively painless, it still is chemotherapy and can lead to other side effects. Surveillance should always be considered as a viable option for men with Stage I disease.
John S, one of the TC survivors on our email support list, did some research into the bleomycin question. He asked a couple of
doctors about problems associated with oxygen exposure. He learned that
the more Bleo you receive, the greater the risk of this pulmonary
toxicity. Most doctors don't worry too much about this side effect
until you're up in the 300-400 units range. His doctor recommended a MedicAlert
bracelet for a year or two just in case you're knocked unconscious
and they decide to put you on oxygen. However, he said that if it's
life-threatening situation, it's best to get the oxygen. Ditto for
oxygen masks on an airplane. If they drop down, put them
on.
The other question he had concerned scuba diving. After all, you're
not breathing concentrated oxygen, just compressed oxygen. He consulted
with Daniel A. Nord from the DAN Medical Staff. DAN (Diver's Alert
Network) is an organization dedicated to dive safety and medical
issues. Daniel wrote back explaining that, "Bleomycin is a cytotoxic
drug of particular importance to divers as it causes pulmonary toxicity
in generally 4% of patients, usually in the form of
pneumonitis/fibrosis. Even in patients with no obvious pulmonary
toxicity, the lungs are sensitized to raised levels of inspired oxygen,
causing an adult respiratory distress syndrome. In general, anyone who
has had bleomycin should not be exposed to partial pressures of oxygen
greater than 0.3 ata's, approx. 15 feet salt water on normoxic air.
Sorry to have to advise that from a medical perspective, diving is
not recommended. If you would like to discuss this in further
detail, please feel free to contact this office directly at (919)
684-2948."
We asked Dr Nichols about the issues associated with bleomycin. He
told us, "that patients who received bleomycin should always make sure
that, now and forever, their doctors and anesthesiologists should be
reminded about this before any surgery or sedation. I suspect the risk
of O2 toxicity declines over time, but as far as I know this
is unknown. I don't think any additional information need be related to
medical personnel and always, if oxygen is required in a life
threatening emergency (eg heart attack or respiratory arrest etc.) it
should be given." We have also asked Dr Lawrence Einhorn at Indiana
University about the same thing, and his position is that the a good
part of bleomycin toxicity issue is overstated and the negative aura has
grown over time without any medical evidence.
So there you have it: Put on the mask, sell your respirator and
tanks, and buy a medical alert bracelet or necklace! Or not... Keep your
eyes open. I hope to give this issue more space in the near future.
Salvage Chemotherapy
Salvage chemo.
It doesn't have a nice ring to it, does it? Well, truth be told, not
everyone with testicular cancer is going to be cured by the first
attempt at chemotherapy. But just because the first chemo fails to cure
does not mean that all is lost. Depending on the type and timing of the
recurrence, many patients can still be cured of their disease.
No matter when the recurrence, be it 1 month or 10 years after
chemotherapy is finished, I strongly recommend that the patient's
doctor contact one of the experts on our experts list to learn about the proper way to treat
the problem. There is a lot of research in this area, and new treatments
are being tried all of the time. Be aware that more than one study has determined that getting treated by an
expert will improve your chances for survival. The experts know what
they are doing and are willing to share this information. Please make
use of them. The articles and links listed below also have some good
information.
This may sound stupid, but it is very important that salvage therapy
is not given unless a relapse is clearly occurring and is documented by
a biopsy or a clearly rising and significant levels of markers. It is
not that rare for patients to be mistakenly classified as having
recurrent disease based on false-positive markers or abnormal x-ray
results. Some of these false-positive results may be due to a growing
teratoma (which still would require surgery), pseudonodules from
bleomycin-induced pulmonary disease, or elevated markers from other
causes such as elevated b-HCG from marijuana usage or cross-reactivity
with luteinizing hormone, or elevated AFP associated with hepatitis or
liver dysfunction. Tests can and should be done to ensure that a
slightly positive marker level is really due to cancer and not something
else! Another cause of persistently elevated markers is a tumor
sanctuary site (eg, in the testis or brain). Now, this is still cancer,
but it may be treated differently than recurrent cancer in the abdomen.
Most salvage chemotherapy for testicular cancer is VeIP with or without
high dose therapy, and this protocol results in 30-50% of patients being
cured assuming that they are not cisplatin refractory. During
this type of therapy, it is generally routine to prescribe G-CSF. Be aware that
chemo may not be a solution, so it is important that you explore
surgical options as well.
A Few Important Final Tips
Chemotherapy is a complicated subject. The drugs used can make you
sick, typically much sicker than you felt from the cancer alone. There
are many different drugs used and many different ways to use those
drugs. Oncology may seem like a cookie cutter / recipe driven way to
cure cancer, but it is not. Experience does count, and if your doctor
does not have a lot of experience with testicular cancer, you might want
to ask them review your treatment with their peers and with an expert.
Over the years, we have learned a few things about the administration
of chemotherapy for testicular cancer. Discuss this information with
your doctor, and make sure that both of you agree how to deal with these
issues before starting chemo.
Chemotherapy usually has some effect on the immune system. With many
chemotherapy protocols, it is not unusual for the oncologist to delay a
cycle if a patients white count is below a certain level. This is not
the case with testicular cancer. If a patient is receiving BEP, EP, or
VIP, each cycle and dose of chemo should be given on schedule
regardless of the white count!
For example, a patient wrote, "I was supposed to get my dose of
Bleomycin today, but my white blood cell count had dropped too low. The
doc is now recommending both abstaining from the bleo, and waiting an
extra week to begin my next cycle in order to let the count come back
up. I consulted with another Oncologist -- mine wouldn't return my
calls. This other doc said that, given how low my white cell count is,
he'd (pretty strongly) recommend Neupogen to boost the count."
Dr Nichols' response was, "The Bleo should be given since it doesn't
really effect the white count. We always give Bleo irrespective of the
white blood cell count. We don't usually add neupogen at this point
since it takes several days to work, and he already is starting to
recover. His next cycle should be initiated as planned irrespective of
the white count. Patients are almost always recovering at that point."
I later asked Dr Nichols specifically, "Under what circumstances
would you postpone the start of the next BEP cycle? Would your answer
change if the protocol was VIP?" He says that, "The correct answer is
very rarely for any circumstances related to myelosuppression. What we
do is start virtually everyone on the correct day and watch their counts
over the 5 days. If, and this is very uncommon, the white count doesn't
start to rise we hold the last day of etoposide. Most everyone has a
rising white count at that juncture. There is little to no evidence
that holding chemotherapy until the white count reaches an arbitrary
number is safer."
Finally, I asked him about the consequences of delaying a cycle. He
told me that, "There is published data that delaying a cycle by more
than 7 days does worsen the results. There is also data that a lower
cisplatin dose intensity, measured in mg/m2/week, does worse. The
standard EP dose intensity is 33 mg/m2/wk and we know that 20/mg/m2/week
is worse. No one knows whether a 3 day delay is harmful, but it
certainly is inconvenient to not get your chemo on time, and there is no
evidence that waiting until an artificially determined number of white
cells has anything to do with risk of infection. This is a very
unscientific area." I get a lot of questions about Neupogen, so I asked Dr Nichols, "What
is Neupogen, and when would you use it?" He responded, "Neupogen (trade
name for filgrastim or G-CSF) is a product that is used to prevent
severe lowering of the white blood cell count associated with
chemotherapy. It usually given by subcutaneous injection daily
beginning the day after chemotherapy ends and for 7-10 days thereafter.
The general recommendations for use in patients is as follows: I don't
use this routinely in patients with good risk disease receiving 3 cycles
of treatment. I would give it in this setting if the patient developed
a fever associated with a low white count during the prior cycle of
chemotherapy. We also consider it in patients with poor risk disease
who are getting 4 cycles of chemotherapy and in all patients receiving
salvage chemotherapy and all patients undergoing stem cell transplant.
It is a very well tolerated medicine with the exception of sometimes
causing bone pain from expansion of the bone marrow white cells. A
similar drug (GMCSF, Leukine) is also sometimes used rather than
G-CSF" The tumor marker levels are a very important and convenient way to
gauge the progress of chemotherapy. However, sometimes they go up after
the first cycle. That does not mean that the chemo is not working. Dr
Nichols notes that, "Sometimes there is a surge of markers with
initiation of therapy, sometimes the markers are rising rapidly before
and you catch it on an up phase. The practical aspect is that very
rarely would I let the markers values at cycle two make me change or
abandon therapy for first line treatment." Back in the old days the treatment for testicular cancer was always
done as an inpatient in the hospital. They did this so that they could
constantly force fluid into the patient to ensure that there was no
kidney damage. Nowadays, they've decided that this is overkill, and most
people are healthy enough to take their chemo as an outpatient.
Nevertheless, it is still important to drink as much as you can and to
get the proper amount of fluid during the chemo infusion. Dr Nichols
says that, "Most people would require a liter of normal saline before
cisplatin, more with the etoposide (usually 500 cc) and a liter
afterwards. So the patient should receive somewhere between 2.5 and 3
liters of fluid. Even at 500cc an hour, which is fast, this will take
most of the day." Cancer can happen to you at any time of the year. Strangely, though,
a lot of doctors and hospitals will try to get you to postpone your
chemo because of holidays. That is not acceptable. If you begin
chemotherapy in mid November, you could get moved around all over the
place due to Thanksgiving, Christmas and New Years. Don't let them get
away with this. As Dr Nichols says, "We make arrangements to treat our
patients through the holidays on schedule. Cancer doesn't observe
Thanksgiving..." We mentioned before that Bleomycin can cause lung damage. Given the
doses used in the standard chemotherapy protocols, the odds of this
happening are very low. Nevertheless, make sure that the doctors are
listening to your lungs periodically to check for this, and if you are
experiencing symptoms such as a cough or shortness of breath, bring this
to the attention of your doctor immediately. For more detailed information on chemotherapy and testicular cancer,
please check out the following links: